Bioiberica S.A.U.

Trending Articles

  1. From RAGs to riches: AI in pharma Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier, reflects on the growth and future of AI in the pharmaceutical industry
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. Santhera and Clinigen partner to distribute DMD treatment AGAMREE to eligible patients globally Clinigen Group will be respsonsible for the distribution of Duchenne muscular dystrophy (DMD) treatment AGAMREE (vamorolone) in regions not currently covered by Santhera or its...
  4. Neuraxpharm bolsters its CNS-targeting therapeutic range with narcolepsy drugs Nuvigil and Provigil By acquiring Teva Pharmaceutical's Nuvigil and Provigil, Neuraxpharm hopes to enhance its narcolepsy offering, while also expanding its global presence
  5. NMD Pharma's drug candidate for Charcot-Marie-Tooth disease granted ODD by the FDA The small molecule CIC-1 inhibitor will be used to treat CMT, which currently has no approved treatments

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Ingredients

Bioiberica presents its potent API solutions at CPHI Milan

The company will be on hand to discuss its APIs and ingredients for pharmaceutical products, as well as its circular economy model
Ingredients

Bioiberica launches natural origin thyroid API

The company is also investigating new opportunities in glycosaminoglycans, complex lipids, proteins and bioactive peptides of non-recombinant origin

Bioiberica to explore new partnerships at CPhI 2019

The Bioiberica team will be at stand 61D51 to explore new partnerships with drug manufacturers
Marketing

Bioiberica modernises brand

The life science corporation has updated its brand image and website
Pharmaceutical

Bioiberica names Luis Solera new CEO
Subscribe now